Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_67dd1f39f37bac4617e37d6d5c60aa8b |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
filingDate |
2007-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d8f96764e57a48ef4d6121723b3d9b2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67e9c58da0bd5a2cc4fa0f9f4dd38bb7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a41269b36c3dd9262f27e58ca499c501 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0ee17c823188f266b2519b271337c1c |
publicationDate |
2012-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2520577-A1 |
titleOfInvention |
Pyrazolo[1,5-a]pyrimidine compounds as CB1 receptor antagonists |
abstract |
The present invention provides pyrazolo[1,5-a]pyrimidine compounds and pharmaceutically acceptable salts thereof having CB1 receptor-antagonizing activity. These compounds, and compositions comprising the same, are hence useful in the treatment of a wide range of conditions and diseases. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108137602-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108137602-A |
priorityDate |
2006-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |